No Data
No Data
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript
X4 Pharmaceuticals Unveils Corporate Presentation for Investors
X4 Pharmaceuticals (XFOR) Gets a Buy From Piper Sandler
Buy Rating Affirmed on X4 Pharmaceuticals: A Comprehensive Analysis of Financial Stability and Drug Development Progress
10-Q: Q2 2024 Earnings Report
104476495 : h
Yolion : should I sell all my shares?